Suppr超能文献

CD4+和CD8+细胞毒性T淋巴细胞对HIV蛋白Env、Gag和Pol的等效识别。

Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes.

作者信息

Kundu S K, Merigan T C

机构信息

Center for AIDS Research, Stanford University Medical Center, California 94305.

出版信息

AIDS. 1992 Jul;6(7):643-9.

PMID:1354446
Abstract

OBJECTIVES

Cytotoxic T-lymphocytes (CTL) appear to be an important defense mechanism against HIV infection. This study proposes to examine the major histocompatibility complex (MHC)-restricted HIV-1 Env-, Gag- and Pol-specific CTL activities in HIV-infected asymptomatic patients.

DESIGN

CD4+ and CD8+ CTL were examined to establish whether the same HIV-1 protein (Env, Gag or Pol) was recognized by both CD4+ and CD8+ CTL with MHC antigen restriction.

METHODS

Peripheral blood mononuclear cells, CD4+ and CD8+ T-cells from 17 HIV-infected asymptomatic patients and 10 HIV-seronegative individuals were examined for HIV-1 Env-, Gag- and Pol-specific MHC-restricted cytotoxicity using autologous and heterologous B-lymphoblastoid cell lines infected with vaccinia recombinant expressing HIV-1 Env, Gag and Pol proteins as targets.

RESULTS

CD4+ and CD8+ CTL specific for the HIV-1 Env, Gag and Pol were demonstrated in the peripheral blood. DR4 and DQw2 were possible sites of MHC class II restriction of CD4+ CTL. Possible MHC class I restriction sites of CD8+ CTL included A2 and B8 for Env, A1 and A2 for Gag, and A2 and B8 for Pol antigen.

CONCLUSIONS

These observations should help to define more precisely the nature and elements of protective immunity and to evaluate AIDS vaccine strategies.

摘要

目的

细胞毒性T淋巴细胞(CTL)似乎是抵御HIV感染的一种重要防御机制。本研究旨在检测HIV感染无症状患者中主要组织相容性复合体(MHC)限制的HIV-1包膜蛋白、核衣壳蛋白和聚合酶蛋白特异性CTL活性。

设计

检测CD4⁺和CD8⁺CTL,以确定CD4⁺和CD8⁺CTL是否在MHC抗原限制下识别相同的HIV-1蛋白(包膜蛋白、核衣壳蛋白或聚合酶蛋白)。

方法

使用感染了表达HIV-1包膜蛋白、核衣壳蛋白和聚合酶蛋白的痘苗重组体的自体和异基因B淋巴母细胞系,检测17例HIV感染无症状患者和10例HIV血清阴性个体的外周血单个核细胞、CD4⁺和CD8⁺T细胞的HIV-1包膜蛋白、核衣壳蛋白和聚合酶蛋白特异性MHC限制的细胞毒性。

结果

在外周血中证实了针对HIV-1包膜蛋白、核衣壳蛋白和聚合酶蛋白的CD4⁺和CD8⁺CTL。DR4和DQw2可能是CD4⁺CTL的MHCⅡ类限制位点。CD8⁺CTL可能的MHCⅠ类限制位点包括针对包膜蛋白的A2和B8、针对核衣壳蛋白的A1和A2以及针对聚合酶蛋白抗原的A2和B8。

结论

这些观察结果应有助于更精确地界定保护性免疫的性质和要素,并评估艾滋病疫苗策略。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验